Global Prefilled Syringes Market 2018 Scope Overview and Regional Trends By 2026
Prefilled syringes
are ready to use pharmaceutical products used to deliver parenteral
medications. These are mainly used for treatment of chronic
conditions that require long-term and self-administration of
medication. Prefilled syringes are the ideal choice for single-dose
drugs, offering easy-to-use fixed dosage options, thereby helping
pharmaceutical companies control costs by minimizing drug overfill,
minimize m icrobial contaGlobal Prefilled Syringes Market 2018
Scope Overview and Regional Trends By 2026mination and reduce dosing
errors. Prefilled syringes make injections easier and safer for both
doctors and patients, with the patient always receives the right
amount of dosage without complications.
Request
For A Sample Copy Of This Research Report:
https://www.coherentmarketinsights.com/insight/request-sample/162
The prefilled
syringes market is expected to gain steady traction in the
foreseeable future, with the success and growth of biologics,
increased global vaccination, increased drug self-administration
trend, technological advancements in the manufacture of PFS, and
development of advanced PFS would further augment market growth. For
instance, Safelia auto injector developed by Nemera in 2017 won the
‘Patient Centricity & Customization’ innovation award at
Pharmapack. Safelia is an innovative auto injector for prefilled
syringes, available in variable sizes, suitable for large volume and
high viscosity delivery through thinner needles.
Market Dynamics
Minimum environment
exposure, easy administration, better patient compliance and 100%
bioavailability are the factors expected to drive the prefilled
syringes market growth in the forecast period. According to the World
Journal of Pharmacy and Pharmaceutical Sciences 2016, more than 3.5
billion prefilled syringes are produced and used annually by patients
and healthcare providers for the treatment of broad spectrum of
conditions. The technological innovations and developments of
prefilled syringes are contributing to the market growth. For
instance, Gerresheimer introduced metal-free Luer Lock Gx RTF Syringe
in 2017, without tungsten to create perfect primary packaging
material for the biotechnologically manufactured active ingredients
that ideally exclude the possibility of contamination with metal.
However, availability of alternative systems such as nanopatches,
microneedles, connected delivery devices, limited shelf life and
stability issues of the drugs are the factors restraining the market
growth.
Market Taxonomy
This report segments
the global prefilled syringes market on the basis of drug type,
material and geography. On the basis of product type, the prefilled
syringes market is categorized into biologics, vaccines, insulin and
others. Biologics are further categorized into monoclonal antibodies,
blood products and others. Vaccines are further categorized into
conjugated vaccines, live attenuated vaccines, recombinant vaccines
and others. On the basis of material, the prefilled syringes market
is categorized into glass and plastic/polymer. For comprehensive
understanding of market dynamics, the global prefilled syringes
market is analyzed across key geographical regions namely North
America, Latin America, Europe, Asia Pacific, Middle East and Africa.
Each of these regions is analyzed on basis of market findings across
major countries in these regions for a macro-level understanding of
the market.
Key features of
the study:
This report provides
in-depth analysis of the prefilled syringes market and its
application, market size (US$ Million) and Cumulative Annual Growth
Rate (CAGR (%)) for the forecast period: 2017 – 2025, considering
2017 as the base year.
It elucidates
potential revenue opportunity across different segments and explains
attractive investment proposition matrix for this market.
This study also
provides key insights about market drivers, restraints,
opportunities, new product launches or approval, regional outlook,
and competitive strategy adopted by the leading players.
It profiles leading
players in the global prefilled syringes market based on the
following parameters – company overview, financial performance,
product portfolio, geographical presence, distribution strategies,
key developments and strategies and future plans.
Key companies
covered as a part of this study include Becton Dickinson &
Co., Gerresheimer, Medtronic, Baxter International, SCHOTT AG, West
Pharmaceuticals, Vetter International, Unilife Corporation, Stevanato
Group and Terumo Corporation.
Click To
Read More On Global
Prefilled Syringes Market
About
Coherent Market Insights:
Coherent Market
Insights is a prominent market research and consulting firm offering
action-ready syndicated research reports, custom market analysis,
consulting services, and competitive analysis through various
recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Comments
Post a Comment